JC108 (O&G) - Pelvic Mass: Ovarian Cancer & Cysts, Uterine Fibroid, Pelvic Imaging Flashcards

1
Q

Outline history taking questions for pelvic mass

A
Mass: 
 Size, site
 Onset; how the mass was discovered
 Duration; change since first noted
 Associated symptoms (e.g. distension, pressure symptoms)
Menstrual history:
 Timing: duration, cycle length
 Amount of flow
 Anaemic symptoms
 Compare with previous pattern
 Any Pain/ dysmenorrhea
Others:
 Previous gyn exam, cervical smear
 Obstetrical history (affects management)
 Sexual history, contraception
 Drug, allergy
 Family
 Medical/surgical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Uterine fibroids

  • cell of origin
  • Presentation, S/S
  • Major ddx
A
Uterine fibroids (leiomyomas)
- benign smooth muscle tumor

Symptoms/ signs:
- multiple, asymmetrical uterine enlargement

  • Submucosal fibroid increase surface area of endometrium - menorrhagia** (different from ovarian cyst, ovarian cancer)
  • mass effect and pressure effect: Abdominal distention, AROU, DVT, change in bowel habit
  • Clotting in uterus or fibroid enlarges into polyp, causing dysmenorrhea ** (like ovarian cyst, cf ovarian cancer) when uterus contracts

Top Ddx: adenomyosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ddx benign ovarian masses

A

 Physiological/ functional cysts (appear with menstruation)
 Endometriomas (endometriotic cyst/ chocolate cyst)
 Serous cystadenoma
 Mucinous cystadenoma
 Mature teratoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ddx benign non-ovarian adnexal masses

A

Benign non-ovarian (ovary next to fallopian tube and mesosalpinx)

 Hydrosalpinges (blocked fallopian tube)

 Paratubal cyst
 Peritoneal pseudocysts

 Tubo-ovarian abscess
 Appendiceal abscess
 Diverticular abscess

 Pelvic kidney
 Distended bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ddx primary and secondary malignant ovarian masses

A

Primary
 Germ cell tumour
 Epithelial carcinoma
 Sex-cord tumour

Secondary
 Breast
 Gastrointestinal (e.g. stomach  Krukenberg tumor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Types of uterine fibroids

Histological features

A

Types

  1. Submucosal
  2. Intramural
  3. Subserosal
  4. Pedunculated
  5. Intraligamentary
  6. Parasitic
  7. Cervical
  8. Intracavitary

Histology: Degenerative changes:
hyaline, myxoid, calcific, cystic, hemorrhagic/red, sarcomatous (may be
malignant – leiomyosarcoma, rare), fatty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ovarian cyst

  • Presentation
  • Top ddx
A

S/S:

  • Asymptomatic if small, mobile, separated from uterus, +/- tender
  • Mass effect: abdominal distension, pressure symptoms, abdominal pain
  • Cyst complications: Torsion, hemorrhage, rupture
  • Dysmenorrhea

Top Ddx:
Endometriosis, endometriotic cyst (less mobile, adhesions to uterus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ovarian cancer

  • Presentation
  • Top ddx
A

S/S: Similar to ovarian cysts and fibroids except no menorrhagia, constitutional and metastatic symptoms:

  • Asymptomatic if small
  • Mass effect and pressure symptoms: Abdominal distension, abdominal pain, ascites, DVT, AROU, bowel function
  • Complications: hemorrhage, rupture
  • Constitutional: LoW, LoA, Unexplained fever
  • Metastatic symptoms: PR bleed, cough, IO…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 surgical emergencies a/w ovarian cysts

A

Torsion: compromises blood supply, but necrosis of ovary is irreversible > treat by de-torsion and cystectomy

Rupture: ovary is highly vascular > severe bleeding and hemoperitoneum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Physical findings:

Pallor
Asymmetrical mass, irregular, in pelvis, firm, non-tender, moves with cervix

Top ddx

A

Uterine fibroids

Ddx of gynaecological masses:
If regular shape mass - adenomyosis
if tender - ovarian cysts 
if fixed - ovarian cancer 
if peritoneal signs - ovarian cyst with torsion and hemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
Physical findings: 
Pelvic mass found separated from uterus 
Tender 
Mobile 
Peritoneal signs 

Most likely gynaecological mass?

A

Ovarian cyst with torsion or hemorrhage leading to peritonitis

If less mobile - adhesions with surround structures, endometriosis, stuck to uterus and becomes endometriotic cyst
If ascites - Meig’s syndrome: triad of benign ovarian tumor
+ ascites + pleural effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define Meig’s syndrome

A

triad of benign ovarian tumor + ascites + pleural effusion,

resolves after tumor resection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Physical findings:

Cachexic, lymphadenopathy, DVT
Pelvic mass is non-tender, fixed, hard, irregular surface
Ascites
Organomegaly
Nodular deposits in Pouch
Stony dull percussion on respiratory exam

Most likely gynaecological mass?

A

Ovarian cancer

Ascites (shifting dullness due to peritoneal metastasis/ liver metastasis
= stage IV
Nodular deposits in Pouch of Douglas (sign of peritoneal metastasis)
Pleural effusion – stony dull (sign of metastasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline P/E for pelvic mass

A

General:

  • vital signs, BMI, performance status, pallor, lymphadenopathy
  • pregnancy test

Abdominal: Full set

Pelvic:
 Vulva, vagina, cervix (speculum)
 Uterine size
 Adnexal mass: size, tenderness, mobility with uterus, arising from pelvis
 Pouch of Douglas: nodularity, thickening, tenderness

Metastasis: Respiratory examination, rectal examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Uterine fibroid

Describe features of the mass on P/E

A

Mass:

  • Symmetrical/ asymmetrical
  • Irregular shape
  • Usually non-tender
  • Moves with cervix
  • Arise from pelvis
  • Consistency varies: firm if calcified, rubbery if normal

Special notes:

  • If tender&raquo_space;> Red degeneration due to fast fibroid growth under hormonal stimulation, outgrowing vessels and causing ischemia
  • Special locations: pedunculated mass - very mobile, subserosal fibroid does not present as a uterine mass
  • Pallor&raquo_space;> severe menorrhagia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ovarian cyst

Describe features of the mass on physical exam

A

Mass:

  • Non-palpable if small
  • Separated from uterus
  • Tender
  • Mobile
  • Soft
  • Does not move with cervix

Special notes:

  • If complicated with hemorrhage or torsion&raquo_space; peritoneal signs and severe abdominal pain
  • If stuck on uterus with adhesions and moves with cervix&raquo_space; endometriotic cyst or ovarian cyst adhered to uterus
  • If pleural effusion&raquo_space; Meig’s syndrome
17
Q

Ovarian cancer

Features of the mass on physical exam

A

Mass:

  • Arise from pelvis
  • Non-tender
  • Hard consistency
  • Irregular surface
  • Mobile or fixed

Signs of metastasis: lymphadenopathy, DVT, pleural effusion, organomegaly, nodular deposits in Pouch of Douglas (peritoneal met.)

18
Q

Most common gynaecological masses

A
Uterine fibroid 
Ovarian masses: e.g. cysts, cancer 
Adenomyosis 
Paraovarian cysts 
Hydrosalpinx 
Pregnancy
19
Q

First-line investigations for pelvic mass

A

Pelvic ultrasound:
Transabdominal for large fibroids
Transvaginal for small fibroids
Sonohysterogram for fibroid polyp, endometrial polyp

Menorrhagia - CBC with diff. for anaemia

Ovarian cancer - CA125 , imaging by CT, MRI, PET-CT

20
Q

Radiological features of uterine fibroids

A
  • Well- circumscribed
  • pseudocapsule from surrounding compressed myometrium
  • Hypoechoic/ heterogeneous echoes
21
Q

5 metrics to describe an adnexal mass on ultrasound

A

Size

Laterality

Cyst content

Septations

Ascites

22
Q

7 different types of cyst content in an adnexal mass ultrasound

A

Benign content:

  • Anechoic (black)
  • Low-level echoes with thin septum (homogenous low echogenicity): old bleed from endometriotic cyst, hemorrhagic cyst

Non-specific content:
- Ground glass appearance (homogeneous dense echoes): e.g. mucinous cystadenoma

Malignant content:

  • Hemorrhagic (thread-like fibrin strands)
  • Mixed (heterogeneous echoes): tooth-like structure in teratoma, papillary growth in malignant tumors
  • Mixed with blood-fluid or fat-fluid level
  • Mixed with abscess
23
Q

Indicators of benign vs malignant pelvic mass on USG

A

International Ovarian Tumor Analysis (IOTA) simple rules:

Benign (B-rules)
 Unilocular cyst
 Smooth multilocular with largest diameter <100mm
 Largest solid component <7mm
 Acoustic shadowing (purely cystic)

Malignant (M-rule)
 Irregular multilocular/ Solid-cystic mass (thick septum)
 >4 papillary structures (>3mm in height)
 Irregular solid tumor with largest diameter >100mm
 Ascites
 Strong intratumoral color flow

Classified malignant: >1 M feature + no B feature
Classified benign: >1 B feature + no M feature
Inconclusive: no B/M features, or both B+M features

24
Q

CA125

  • Molecular structure
  • Produced by which cells
  • Cut-off level
A

celomic epithelium-related glycoprotein

Present in most serous (high-grade), endometrioid, and clear cell ovarian carcinomas (mucinous tumors express it less frequently)

Present in epithelium of fallopian tubes, endometrium, and uterine cervix

usual cutoff = around 35 u/ml

25
Q

Confounding factors that increase CA125 concentration

A

Elevated in anything irritating mesothelium/ epithelium:

 Menstruating, pregnant women
 Endometriosis/ endometriotic cyst (20-30%)
 Fibroids
 Benign ovarian tumours (10%)
 Acute PID
 Liver cirrhosis (60-70%) >>  ascites
 Pancreatitis (30%) >> ascites
 COPD, kidney problem, flu, CA breast, CA lung etc.
26
Q

CA125

Practical clinical uses

A
  • More sensitive and specific in postmenopausal women

- Useful in follow-up of patients after treatment for proven CA ovary with elevated CA 125 level before treatment

27
Q

Index for risk of ovarian cancer based on CA125 levels

A

Risk of malignancy index (RMI):

RMI = U x M x CA125

U = ultrasound features 
M = 3 for all post-menopausal women 
CA-125 = measurement in u/mL

Low risk = RMI < 25 = 3% risk of cancer
Moderate risk = 25-250 RMI = 20% risk of cancer
High risk = RMI >250 = 75% risk of cancer

28
Q

Uterine fibroids

  • Treatment options
A

Asymptomatic = observation and reassurance

Symptomatic:
Symptom relief by:
- transamin/ tranexamic acid to stop bleeding
- Mirena (IUCD secreting progestogens to decrease menstrual flow)

Surgical removal: if mass effect or pressure effect is severe:

  • Myomectomy/ Hysterectomy
  • Approach: open/ laparoscopic/ vaginal/ hysteroscopic

Minimal invasive:

  • Uterine artery embolisation
  • High intensity focused ultrasound
29
Q

Indications for different types of surgical treatment for uterine fibroids

A

Small fibroid = vaginal approach myomectomy
Deep fibroid to submucosal level = full-thickness myomectomy
Submucosal fibroid/ fibroid polyp = hysteroscopic resection
Large fibroid = open approach myomectomy or hysterectomy

No fertility wish: hysterectomy, UAE, HIFU

30
Q

Adnexal mass/ cyst

Treatment options for pre-menopausal women

A

Simple, functional cysts, asymptomatic, <5cm = close case

Simple, functional cysts, asymptomatic, 5-7cm = observe and repeat ultrasound in 3-6 months for regression

Persistent cyst/ increases in size or >7cm:

  • Cystectomy or salpingo- oophorectomy
  • Approach: Laparoscopy (small)/ laparotomy (big or suspicious-looking)

Symptomatic mass/ suspect cancer:

  • Refer gynecology
  • Exclude secondary from colon, stomach, breast…etc
  • Staging surgery +/- chemotherapy
31
Q

Adnexal mass/ cyst

Treatment for post-menopausal women

A

Asymptomatic + simple + unilateral + unilocular + <5cm + normal CA125: repeat assessment in 4-6 months
- consider intervention (prophylactic removal) if change in feature

All other cysts (i.e. symptomatic/ non-simple features/ >5cm/ multilocular/ bilateral):
- BSO (bilateral salpingo-oophorectomy) by laparotomy/ laparoscopy approach

RMI>200:

  • CT scan (abdomen, pelvis) or laparotomy
  • Low likelihood of malignancy: pelvic clearance (total abdominal hysterectomy) + BSO + omentectomy + peritoneal cytology
  • Malignant: surgery, chemotherapy, targeted therapy
32
Q

Ovarian cancer

Treatment options for early and late stage

A

Early stage: surgery (histological diagnosis + treatment) +/- chemotherapy

Late stage: stage: surgery and chemotherapy +/- targeted therapy